p53 deletion yields high response rates but rapid progression and poor overall survival in multiple myeloma patients undergoing autologous stem cell transplantation

被引：2
|
作者：
Mikhael, Joseph R. [1 ]
Goodwin, Jodi [1 ]
Qi, Xiaoying [1 ]
Xu, Wei [2 ]
Stewart, Keith [1 ]
Reece, Donna [1 ]
Chen, Christine [1 ]
Trudel, Suzanne [1 ]
Kukreti, Vishal [1 ]
Chang, Hong [2 ]
机构：
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[2] Univ Hlth Network, Toronto, ON, Canada
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.953.953
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
953
引用
收藏
页码：290A / 290A
页数：1
相关论文
共 50 条
  • [41] NO EVIDENCE FOR IMPROVED OVERALL SURVIVAL OR PROGRESSION-FREE SURVIVAL IN MULTIPLE MYELOMA PATIENTS AGED 70-75 UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION COMPARED TO A NON-TRANSPLANT STRATEGY
    Riva, Eloisa
    Kastritis, Efsthathios
    Gras, Luuk
    Koster, Linda
    Caillot, Denis
    Tucci, Alessandra
    Lanza, Francesco
    Musso, Maurizio
    Sirvent, Anne
    Illes, Arpad
    Ram, Ron
    Bonifazi, Francesca
    Bourhis, Jean Henri
    Zuckerman, Tsila
    Mizuno, Shohei
    Roussou, Maria
    Dimopoulos, Meletios A.
    Mian, Hira S.
    Atsuta, Yoshiko
    Snowden, John
    Sureda, Anna
    Aljurf, Mahmoud
    de Wreede, Liesbeth C.
    Hayden, Patrick J.
    McLornan, Donal
    Niederwieser, Dietger
    Garderet, Laurent
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 366 - 367
  • [42] Impact of autologous stem cell transplantation on long term renal function and associated progression-free and overall survival in multiple myeloma
    Abudayyeh, Ala
    Lin, Heather
    Mamlouk, Omar
    Abdelrahim, Maen
    Saliba, Rima
    Rondon, Gabriela
    Martinez, Charles S.
    Delgado, Ruby
    Page, Valda
    Rajasekaran, Arun
    Sanders, Paul W.
    Qazilbash, Muzaffar
    LEUKEMIA & LYMPHOMA, 2020, 61 (13) : 3101 - 3111
  • [43] Genomic Aberrations and Survival of Patients with Light-Chain-Only Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
    Jiang, Nan
    Qi, Connie
    Trieu, Young
    Reece, Donna
    Chang, Hong
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (12) : 1790 - 1795
  • [44] Improved survival in multiple Myeloma patients undergoing autologous stem cell transplantation is entirely in the standard cytogenetic risk groups
    Afram, Gabriel
    Susek, Katharina Helene
    Uttervall, Katarina
    Wersall, Johanna Dehlsen
    Wagner, Arnika Kathleen
    Luong, Vincent
    Lund, Johan
    Gahrton, Gosta
    Alici, Evren
    Nahi, Hareth
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (04) : 546 - 554
  • [45] Outcomes of frail patients undergoing high-dose chemotherapy and autologous stem cell transplantation for multiple myeloma
    Yohay, Stephanie
    Oloyede, Temitope
    Kim, Soyoung
    Fang, Xi
    Dhakal, Binod
    Aijaz, Ayesha
    Mohan, Meera
    Narra, Ravi
    Pasquini, Marcelo
    D'Souza, Anita
    Hamadani, Mehdi
    Freeman, Ciara Louise
    Akhtar, Othman Salim
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (06) : 2370 - 2375
  • [46] Very Good Partial Response and Complete Response Predict Superior Overall Survival and Progression Free Survival After Single Autologous Stem Cell Transplant in Patients with Multiple Myeloma
    Jimenez-Zepeda, Victor H.
    Reece, Donna E.
    Trudel, Suzanne
    Chen, Christine
    Winter, Andrew, Sr.
    Franke, Norman
    Tiedemann, Rodger E.
    Kukreti, Vishal
    BLOOD, 2011, 118 (21) : 1755 - 1756
  • [47] Lack of a caregiver is associated with shorter survival in myeloma patients undergoing autologous stem cell transplantation
    Gertz, Morie A.
    Warsame, Rahma
    Muchtar, Eli
    Buadi, Frances
    Dispenzieri, Angela
    Gonsalves, Wilson
    Dingli, David
    Hayman, Suzanne
    Kapoor, Prashant
    Kourelis, Taxiarchis
    Kumar, Shaji K.
    Lacy, Martha Q.
    Hogan, William
    LEUKEMIA & LYMPHOMA, 2022, 63 (10) : 2422 - 2427
  • [48] Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma
    C Reynolds
    V Ratanatharathorn
    P Adams
    T Braun
    S Silver
    L Ayash
    E Carson
    A Eisbruch
    LA Dawson
    K McDonagh
    J Ferrara
    J Uberti
    Bone Marrow Transplantation, 2001, 27 : 801 - 807
  • [49] Impact of Duration of Induction Therapy on Progression-Free Survival in Patients with Newly Diagnosed Multiple Myeloma Undergoing Upfront Autologous Stem Cell Transplantation
    Chakraborty, Rajshekar
    Muchtar, Eli
    Kumar, Shaji K.
    Buadi, Francis K.
    Dingli, David
    Dispenzieri, Angela
    Haymann, Suzanne
    Hogan, William J.
    Kapoor, Prashant
    Lacy, Martha Q.
    Leung, Nelson
    Warsame, Rahma
    Kourelis, Taxiarchis
    Gonsalves, Wilson I.
    Gertz, Morie A.
    BLOOD, 2017, 130
  • [50] Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma
    Reynolds, C
    Ratanatharathorn, V
    Adams, P
    Braun, T
    Silver, S
    Ayash, L
    Carson, E
    Eisbruch, A
    Dawson, LA
    McDonagh, K
    Ferrara, J
    Uberti, J
    BONE MARROW TRANSPLANTATION, 2001, 27 (08) : 801 - 807
12345